BioTools Innovator Announces the 2023 Finalists
Four Cohort Companies Will Vie for the $250,000 Grand Prize at the
BioTools Innovator Capstone Event on October 12th
LOS ANGELES – September 29, 2023- BioTools Innovator, the first ever accelerator focused on life science tools, announced today the four finalists in its 2023 program. Selected from a 19-company cohort, the finalists will vie for the $250,000 non-dilutive Grand Prize and the title of 2023 BioTools Innovator at the Capstone Event on October 12 in Carlsbad, Calif.
“BioTools Innovator’s mission is to help the foundation of life science – mentoring and support for the cutting-edge companies developing the tools we need to create new therapies and diagnostics,” said Kathryn Zavala, managing director of BioTools Innovator. “Congratulations to the four finalists in this year’s program, who exemplify the quest to improve human health using the building blocks of life science. I look forward to announcing this year’s Grand Prize winner next month in Carlsbad.”
The four finalist companies are:
Andson Biotech (Atlanta) – High-throughput, microfluidic enabled platforms for at-line and inline mass spectrometry
Aopia Biosciences (Pleasanton, Calif.) – NanoEX, a next generation exosome isolation platform unlocking the full potential of EV for diagnostics and therapeutics
BioRaptor (Binyamina, Israel) – The operating system for biotechnology companies, an end-to-end AI powered data platform for high complexity bioprocesses
Limula (Lausanne, Switzerland) – Modular and automated platform for scale down/scale out cell therapy manufacturing.
Located near the Cell & Gene Meeting on the Mesa, the BioTools Innovator Capstone Event brings together senior executives, investors, and top decision-makers in the industry. The event, supported by Thermo Fisher Scientific, features keynote presentations, a company showcase with the BioTools Innovator 2023 cohort and the $250,000 Grand Prize competition. During the competition finals, each of the four finalists will have nine minutes to pitch their technology and answer questions from a panel of judges. After the presentations, the audience will vote in real-time to select the winner.
Register here to attend the event taking place at the Westin Carlsbad Resort and Spa.
As part of a rigorous selection process, together with the senior leadership teams of its corporate partners at Research Corporation Technologies, Broad Oak Capital Partners, Nissan Chemical America Corporation, and over 80 industry judges from leading life science firms, BioTools Innovator evaluated the pitches of 37 candidates out of more than 300 applicants from 26 countries and 28 U.S. states. Nineteen companies were then selected to participate in the BioTools Innovator Accelerator, which prominently features best-in-class life science startups from around the world.
Reviewers and experts that participated in BioTools Innovator pitch events included representatives from Agilent, AstraZeneca, Biomedical Advanced Research and Development Authority (BARDA), Danaher, DeciBio, Draper, Eppendorf, General Inception, Genentech, Genoa Ventures, Illumina Ventures, Jabil, Johnson & Johnson Innovation, MilliporeSigma, Mira Life Science Ventures, NIIMBL, Northpond Ventures, Synthego, Thermo Fisher Scientific, Tosoh USA, Teknova, VC23, among others.
A complete list of the BioTools Innovator 2023 cohort companies can be found here.
BioTools Innovator provides startups with individualized mentorship and feedback, funding opportunities, and continual engagement with peers and advisors. Funding for BioTools Innovator is provided by the Frederick Gardner Cottrell Foundation of Research Corporation Technologies, Inc. (RCT). Additional support is provided by BroadOak Capital Partners and Nissan Chemical America Corporation.
About BioTools Innovator
Based in Los Angeles, BioTools Innovator was established to advance cutting-edge research and improve human health by accelerating the growth of a broad spectrum of life science tools and diagnostics. BioTools Innovator matches industry leaders with innovative early stage and emerging growth biotechnology-focused companies for mentorship and support.
BioTools Innovator is powered by MedTech Innovator, is the world’s largest accelerator of medical technology companies and the premier nonprofit startup accelerator in the medical technology industry. To date, MedTech Innovator has supported 612 alumni that have gone on to raise $7 billion in follow-on funding, brought 281 products to market, and achieved 39 exits.
For more information about BioTools Innovator, visit the website, and follow the program on LinkedIn and Twitter.
MEDIA CONTACT:
Joe Duraes
Pazanga Health Communications
jduraes@pazangahealth.com
(917) 687-6419
